HDAC9 and Global developmental delay: This histone deacetylase (HDAC) inhibitor is contra-indicated during pregnancy as it can cause a range of developmental delays and congenital malformation that are referred to as fetal valproate spectrum disorder (FVSD) or fetal valproate syndrome (40).